CLASS II Device recall · Reported 4 Mar 2020 · FDA Enforcement Report

Advia Chemistry Lipase recalled by Siemens Healthcare Diagnostics

Siemens Healthcare Diagnostics is recalling Advia Chemistry Lipase, distributed nationwide in the US. The recall was initiated on 20 Dec 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codeslot 485700
Quantity recalled3224

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1363-2020
FDA event ID
84768
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Terminated
Recall initiated
20 Dec 2019
FDA classified
26 Feb 2020
Reported
4 Mar 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Dec 2019Recall initiated by company
26 Feb 2020Classified by FDA+68 days
4 Mar 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Firm has received customer complaints regarding failed calibrations and increased imprecision of quality control and patient samples when using this product.

Product as listed by the FDA

ADVIA Chemistry Lipase, Ref. No. 01984894 B01-4840-01, Siemens Material No. 10311896, UDI 00630414482446 - Product Usage: Lipase measurements are used in the diagnosis and treatment of diseases of the pancreas, such as acute pancreatitis and obstruction of the pancreatic duct.

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of AZ, CA, CT, FL, GA, IA, KS, MD, MI, NJ, NM, NY, OH, OK, PA, TN, TX, WA.

Nationwide ArizonaCaliforniaConnecticutFloridaGeorgiaIowaKansasMarylandMichiganNew JerseyNew MexicoNew YorkOhioOklahomaPennsylvaniaTennesseeTexasWashington

Questions about this recall

Why was it recalled?

Firm has received customer complaints regarding failed calibrations and increased imprecision of quality control and patient samples when using this product.

Which lots are affected?

lot 485700

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of AZ, CA, CT, FL, GA, IA, KS, MD, MI, NJ, NM, NY, OH, OK, PA, TN, TX, WA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Other Medical Devices recalls

All 13,778